glp-1 drugs for addiction GLP‑1 May Be the Next Tool in the Fight Against | Health News People taking GLP-1 drugs often

Jun W, Benjanuwattra J, Chattipakorn SC, Chattipakorn N

Kensy et al., 2009)

It is not for the weakkkk

Patients taking GLP-1 RAs, irrespective of drug type, dose, duration of therapy, and absence of symptoms, can have delayed gastric emptying such that not adjusting fasting times might lead to aspiration events in asymptomatic patients

8 weeks (1 vial): 3 mL 1 10 mL bottle 12 weeks (2 vials): 6 mL 1 10 mL bottle 16 weeks (4 vials): 12 mL 2 10 mL bottles Alcohol Swabs: One for the vial stopper + one for the injection site each administration day

Additional cardiovascular outcomes trials for other GLP-1 receptor agonists are in progress, and results are anticipated in the near future